IFM Therapeutics

IFM Therapeutics is transforming treatment for inflammatory disease and cancer by developing drugs that target the innate immune system, the body’s first line of response. IFM was founded in 2015 by an international group of preeminent scientists and physicians who have spent decades understanding innate immunity and the role it plays in the immune system.

Headquarters Boston, MA
Pipeline Preclinical
Twitter @IFMThera